Financiere de Tubize (STU:FTD) Short Percentage of Float


STU:FTD Financiere de Tubize SA STU:FTD
44 GF Score
Price €230.80
! 2 Warning Signs
View Full Analysis

What is Financiere de Tubize Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:FTD vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, Financiere de Tubize's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Financiere de Tubize Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Financiere de Tubize's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Financiere de Tubize's Short Percentage of Float falls into.


STU:FTD
44GF Score
Financiere de Tubize SA STU:FTD
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Financiere de Tubize Business Description

Address Allee de la Recherche, 60, Brussels, BEL, 1070
Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a world-wide biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Majority of its sales revenue is derived from its neurology products, followed by its immunology products. The company's plan focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.
44GF Score

Get the complete analysis for STU:FTD

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€230.80
Price